The importance of family history on the development of renal disease

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 3, 2004, Pages 337-341

  Satko, Scott G ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Diabetes mellitus; End stage renal disease; Family history; Glomerulonephritis; Hypertension; Prevention; Screening

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; DIABETIC NEPHROPATHY; EPIDEMIC; FAMILY HISTORY; FOCAL GLOMERULOSCLEROSIS; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HIGH RISK POPULATION; HUMAN; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY AMYLOIDOSIS; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LINKAGE ANALYSIS; MEDULLARY SPONGE KIDNEY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

GENETIC PREDISPOSITION TO DISEASE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; PEDIGREE; RISK FACTORS;

EID: 2342471905     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200405000-00012     Document Type: Review

References (42)

1. Seaquist ER, Goetz FC, Rich SS, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320:1161-1165.
2. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insuin-dependent diabetes mellitus. Am J Kidney Dis 1995; 25:710-713.
3. Bergman S, Key BO, Kirk KA, et al. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease. Am J Kidney Dis 1996; 27:341-346.
4. Satko SG, Langefeld CD, Daeihagh P, et al. Nephropathy in siblings of African-Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002; 40:489-494.
5. Gitter J, Langefeld CD, Rich SS, et al. Prevalence of nephropathy in black patients with type 2 diabetes mellitus. Am J Nephrol 2002; 22:35-41.
6. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39:940-945.
7. Freedman BI, Wilson CH, Spray BJ, et al. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997; 29:729-732.
8. Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 1999; 34:254-258.
9. Freedman BI. Familial aggregation of end-stage renal failure: aetiological implications. Nephrol Dial Transplant 1999; 14:295-297.
10. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993; 21:387-393.
11. Krolewski AS, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318:140-145.
12. Freedman BI, Bowden DW, Rich SS, Appel RG. Genetic initiation of hypertensive and diabetic nephropathy. Am J Hypertens 1998; 11:251-257.
13. Moczulski DK, Rogus JJ, Antonellis A, et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998; 47:1164-1169.
14. Freedman BI, Colicigno CJ, Sale MM, et al. Replication of diabetic nephropathy (DN) locus on chromosome 18 in African American (AA) families [abstract]. J Am Soc Nephrol 2003; 14:291A.
15. Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62:2176-2183.
16. Freedman BI, Rich SS, Yu H. Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int 2002; 62:770-774.
17. Iyengar SK, Fox KA, Schachere M, et al. Linkage analysis of candidate loci in end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 2003; 14 (Suppl 2):S195-S201.
18. Hunt SC, Hasstedt SJ, Coon H, et al. Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal faiure in the fawn-hooded rat. Kidney Int 2002; 62:1143-1148.
19. Brown DM, Provoost AP, Daly MJ, et al. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 1998; 12:44-51.
20. Scolari F, Puzzer D, Amoroso A, et al. Identification of a new locus for medullary cystic disease, on chromosome 16p12. Am J Hum Genet 1999; 64:1655-1660.
21. Stiburkova B, Majewski J, Sebesta I, et al. Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2- and evidence for genetic heterogeneity. Am J Hum Genet 2000; 66:1989-1994.
22. Bleyer AJ, Woodard AS, Shihabi Z, et al. Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 2003; 64:36-42. A mutation in the uromodulin gene has been associated with the phenotype seen in familial juvenile hyperuricemic nephropathy.
23. Bleyer AJ, Hart TC. Familial juvenile hyperuricaemic nephropathy. Q J Med 2003; 96:867-871.
24. Dahan K, Devuyst O, Smaers M, et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 2003; 14:2883-2893. In patients with familial juvenile hyperuricemic nephropathy, mutations of the uromodulin gene were associated with abnormal accumulation of the gene product within tubular epithelial cells. This provides some insight into the pathophysiological mechanism of this disease.
25. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:862-892. Both medullary cystic kidney disease type 2 and familial juvenile hyperuricaemic nephropathy may be variations of the same disorder, as both are linked to a mutation in the uromodulin gene on chromosome 16p.
26. Rana K, Isbel N, Buzza M, et al. Clinical, histopathologic, and genetic studies in nine families with focal segmental glomerulosclerosis. Am J Kidney Dis 2003; 41:1170-1178.
27. Avila-Casado MC, Vargas-Alarcon G, Soto ME, et al. Familial colapsing glomerulopathy: clinical, pathological and immunogenetic features. Kidney Int 2003; 63:233-239. This is the first report of a family with multiple members suffering from a familial form of collapsing glomerulopathy.
28. Tolkoff-Rubin NE, Cosimi AB, Fuller T, et al. IgA nephropathy in HLA-identical siblings. Transplantation 1978; 26:430-433.
29. Gharavi AG, Yan Y, Scolari F, et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 2000; 26:354-357.
30. Schena FP, Cerullo G, Rossini M, et al. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 2002; 13:453-460.
31. Valleix S, Drunat S, Philit JB, et al. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int 2002; 61:907-912.
32. Freedman BI, Soucie JM, McClellan WM. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997; 8:1942-1945.
33. Molony DA, Brown WM, King K, Gannon M. Screening of high risk populations identifies a high prevalence of individuals with abnormal renal function: the NKF Kidney Early Evaluation Program [abstract]. J Am Soc Nephrol 2000; 11:158A.
34. Brown WW, Bakris GL, Chen SC, et al. Targeted screenings identify persons at risk for kidney disease [abstract]. J Am Soc Nephrol 2001; 12:193A.
35. Jurkovitz C, French H, Shoham D, et al. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis 2002; 40:1173-1178. This cross-sectional survey of over 700 adults with either a family history of ESRD or a personal history of hypertension or diabetes uncovered a high number of asymptomatic individuals with proteinuria and/or renal insufficiency.
36. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
37. Satko SG, Robins V, Arcury T, et al. Family history of end-stage renal disease (ESRD) prevention project [abstract]. J Am Soc Nephrol 2002; 13:255A.
38. Ramirez SP, McClellan W, Port FK, Hsu SI. Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002; 13:1907-1917.
39. Czene K, Hemminki K. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. Kidney Int 2002; 61:1806-1813.
40. Hollowell JG, Greenfield SP. Screening siblings for vesicoureteral reflux. J Urol 2002; 166:2138-2141. This meta-anarysis found a high rate of vesicoureteral reflux in the siblings of children with this disorder.
41. Lackland DT, Bendall HE, Osmond C, et al. Low birth weights contribute to the high rates of early-onset chronic renal failure in the southeastern United States. Arch Intern Med 2000; 160:1472-1476.
42. Fan ZJ, Lackland DT, Kenderes B, et al. Impact of birth weight on familial aggregation of end-stage renal disease. Am J Nephrol 2003; 23:117-120. In this paper, a multiple logistic regression analysis was used to disprove the notion that clustering of either high or low birth weight is associated with the familial clustering of ESRD in subjects residing within the south-eastern US.